Conversations on MS with Dr. Robert Gross, recorded live from Colorado Springs on October 6, 2025. TOPICS ADDRESSED IN THIS SESSION: (Please click the time to be taken to that…
The FDA has extended its review of tolebrutinib, Sanofi’s investigational BTK inhibitor, with a new decision date of Dec. 28, 2025. Sanofi is seeking approval for tolebrutinib to treat non-relapsing…
In this issue of InforMS, we turn our focus to a rarely discussed but deeply important topic: pediatric multiple sclerosis. While MS is most often diagnosed in young adults, it…
For most families, multiple sclerosis is something they associate with adulthood. But MS can also affect children and teens—and while uncommon, the impact can be profound. Pediatric MS is highly…
When Abby Jones was diagnosed with multiple sclerosis at just 14 years old, it marked the beginning of a life-changing journey for her and her family. We spoke with her…
For Ramah, MS has been part of life since childhood. Diagnosed at age 10 after years of unexplained symptoms, she quickly learned how invisible the disease could be to others—and…
Support, education, and connection are key for families adjusting to life with a MS diagnosis. These trusted resources offer tools, guidance, and community for children, teens, and caregivers. The Neuroimmunology…
Finally, we turn our attention to the emotional and psychological experience of pediatric MS. Clinical psychologist Dr. Jennifer Lindwall shares her expertise supporting children, teens, and their families as they…
Big Changes in How Multiple Sclerosis Is Diagnosed: What the New 2024 McDonald Criteria Mean for You
For people living with multiple sclerosis, early and accurate diagnosis is critical. It helps patients begin treatment sooner, manage symptoms more effectively, and improve long-term outcomes. On September 17th, The…
Over the past several years, Coloradans living with chronic health conditions—including MS—have spoken up about barriers to care. Thanks to that advocacy, new state laws now protect patients in Colorado-regulated…